Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

AML Survival in Young People: Race/Ethnicity Assessed

Leuk Lymphoma; ePub 2016 Nov 3; Durani, Go, et al

Publish date:: November 9, 2016

Adolescents and young adults with acute myeloid leukemia (AML) experienced substantial differences in overall survival that appeared to be based on race in a study involving nearly 9,000 individuals.

Participants were between 15 and 39 years of age, and were diagnosed with AML over an 11-year period ending in 2011. Investigators looked at overall survival according to race over the early, middle, and late periods of their analysis. Among the results:

Blacks had 21% higher odds of worse overall survival, compared with whites.
Hispanics had 10% lower odds of such, vs whites.
Overall survival improved over time in whites only, with 1-year survival rates of 69, 72 and 74 months over the 3 time periods, respectively.

Citation:

Durani U, Go R. Racial and ethnic disparities in the survival of adolescents and young adults with acute myeloid leukemia: A retrospective study using the US National Cancer Center Data Base. [Published online ahead of print November 3, 2016]. Leuk Lymphoma. doi:10.1080/10428194.2016.1231312.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in AML

Beat AML: Precision medicine strategy feasible, superior to SOC for AML,

Survey quantifies COVID-19’s impact on oncology,

Combo drug improves survival in older patients with high-risk/secondary AML,

Venetoclax plus LDAC tops LDAC alone in AML,

Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML,